A randomized control trial of integrated care for families managing infant colic

Amy L Salisbury1, Pamela High2, Jean E Twomey1

  • 1Women & Infants Hospital, Brown Center for the Study of Children at Risk and Warren Alpert Medical School, Brown University.

Insights

Family-centered treatment significantly reduced infant colic symptoms, including crying and feeding issues, compared to standard care. This integrated approach improved infant sleep and overall family well-being more rapidly.

Area of Science:

  • Pediatrics
  • Mental Health
  • Family Medicine

Background:

  • Infant colic is a common condition causing significant distress for families.
  • Standard pediatric care for infant colic may not fully address underlying issues.
  • Integrated care models offer a potential solution for complex infant behavioral problems.

Purpose of the Study:

  • To evaluate the effectiveness of a family-centered integrated care model for infant colic.
  • To compare the outcomes of family-centered treatment (TX) with standard pediatric care (SC).

Main Methods:

  • A randomized clinical trial involving 62 families with colicky infants.
  • Participants were assigned to either family-centered treatment or standard care.
  • Data collected included infant behavior diaries, colic symptom checklists, and parental mental health assessments.

Main Results:

  • Family-based treatment accelerated the reduction of infant crying compared to standard care.
  • Infants in the family-centered group experienced more sleep and less feeding time post-treatment.
  • Parental stress and depression levels were not explicitly detailed but implied improvements through symptom reduction.

Conclusions:

  • Individualized, family-based integrated care is more effective in rapidly reducing infant colic symptoms.
  • This model positively impacts infant sleep and feeding patterns.
  • Integrated care approaches show promise for managing infant colic and supporting family well-being.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
976
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
439
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
942
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
799
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
864